Brand names and generic drugs, 1974 [microform] : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974

Chicago citation style
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health. Brand names and generic drugs, 1974 [microform] : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974. 1974. Retrieved from the Digital Public Library of America, http://catalog.hathitrust.org/Record/003217926. (Accessed November 21, 2018.)
APA citation style
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health, (1974) Brand names and generic drugs, 1974 [microform] : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974. Retrieved from the Digital Public Library of America, http://catalog.hathitrust.org/Record/003217926
MLA citation style
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health. Retrieved from the Digital Public Library of America <http://catalog.hathitrust.org/Record/003217926>.
Note: These citations are programmatically generated and may be incomplete.